GPER signaling has been detected in both the cytoplasm and nuclei of tumor cells in NSCLC specimens, and elevated expression levels of this receptor have been associated with advanced tumor stages, lower differentiation grades, and high ERβ expression. The gene discussed is ESR2; the disease is neoplasm.